Investigation on the regulatory T cells signature and relevant Foxp3/ <scp>STAT3</scp> axis in esophageal cancer-Reference-Cited by-同舟云学术

Investigation on the regulatory T cells signature and relevant Foxp3/ STAT3 axis in esophageal cancer

Published:2022-10-13 Issue:4 Volume:12 Page:4993-5008
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Yang Lin¹²,Zhao Qijie²³^ORCID,Wang Xing⁴,Pilapong Chalermchai³,Li Yi¹,Zou Jun²,Jin Jing¹,Rong Jinfeng¹

Affiliation:

1. Department of Oncology The Second Peopleʼs Hospital of Yibin Yibin Peopleʼs Republic of China

2. Department of Pharmacy, West China Hospital Sichuan University Chengdu Peopleʼs Republic of China

3. Center of Excellence for Molecular Imaging (CEMI), Department of Radiologic Technology, Faculty of Associated Medical Sciences Chiang Mai University Chiang Mai Thailand

4. Shichuan Nursing Vocational College Chengdu Peopleʼs Republic of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5194

Reference94 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Oesophageal carcinoma

3. Early Esophageal Cancer: A Gastroenterologist’s Disease

4. Emerging immunotherapy for the treatment of esophageal cancer

5. Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin;PLOS ONE;2024-08-16

2. A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12);OncoImmunology;2024-06-24

3. Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies;Frontiers in Immunology;2024-06-11

4. Cathepsin L promotes oesophageal squamous cell carcinoma development and may be associated with tumour-associated macrophages;Heliyon;2024-04